Marjan Budihna - Concepedia

Author

Marjan Budihna

Institute of Oncology Ljubljana

Also Known As

Lojze Šmid, M Budihna, M V Budihna, M. Budihna, M. V. Budihna, M.V. Budihna, Marjan Budihna

Publications

820

Citations

H-Index

Concepts

All Affiliations

Institute of Oncology Ljubljana Ljubljana University Medical Centre Jožef Stefan Institute University of Ljubljana

About

Marjan Budihna is an author at Institute of Oncology Ljubljana specializing in oncology, medicine, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	16	621
2	Health Sciences	1	1	48
3	Biochemistry	1	1	64
4	Cell Biology	1	1	48
5	Head And Neck Surgery	1	1	58

Marjan Budihna

Publications

736

Citations

H-Index

Page 1

	Year	Citations
Prognostic significance of cysteine proteinases cathepsins B and L and their endogenous inhibitors stefins A and B in patients with squamous cell carcinoma of the head and neck. Primož Strojan, Marjan Budihna, Lojze Šmid, PubMed Breast OncologySquamous Cell CarcinomaCats BPathologyPrognostic Significance	2000	95
Prognostic Value of Cathepsins B, H, L, D and Their Endogenous Inhibitors. Stefins A and B in Head and Neck Carcinoma Marjan Budihna, Primož Strojan, Lojze Šmid, Biological Chemistry Hoppe-Seyler Tumor BiologyCathepsins BMedicineOral CancerPharmacology	1996	75
Cathepsins B, H and L in human breast carcinoma. D Gabrijelcic, Branka Svetic, D. Spaic, PubMed Tumor BiologyBreast OncologyBiochemistryCathepsins BMedicine	1992	64
Postoperative concomitant irradiation and chemotherapy with mitomycin C and bleomycin for advanced head-and-neck carcinoma Lojze Šmid, Marjan Budihna, Branko Zakotnik, International Journal of Radiation OncologyBiologyPhysics Neuro-oncologyRadiation TherapyMitomycin CMedicinePostoperative Concomitant Irradiation	2003	58
Radiotherapy, combined with simulataneous chemotherapy with Mitomycin C and bleomycin for inoperable head and neck cancer—preliminary report Lojze Šmid, Hotimir Lešničar, B Zakotnik, International Journal of Radiation OncologyBiologyPhysics Neuro-oncologyRadiation MedicineRadiation TherapyMitomycin CSimulataneous Chemotherapy	1995	51
Tumor cell repopulation in the rest interval of split-course radiation treatment. Marjan Budihna, J Škrk, Lojze Šmid, PubMed Isoeffect LineSplit-course Radiation TreatmentTumor BiologyRest IntervalRadiation Medicine	1980	48
Urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) in tissue and serum of head and neck squamous cell carcinoma patients Primož Strojan, Marjan Budihna, Lojze Šmid, European Journal of Cancer Tumor BiologyOncologyMedicinePathologyHead And Neck Cancer	1998	45
Concomitant radiotherapy with mitomycin C and bleomycin compared with radiotherapy alone in inoperable head and neck cancer: final report Branko Zakotnik, Lojze Šmid, Marjan Budihna, International Journal of Radiation OncologyBiologyPhysics Neuro-oncologyRadiation MedicineNeck CancerRadiation TherapyMitomycin C	1998	38
Radiochemotherapy with Vinblastine, Methotrexate, and Bleomycin in the treatment of verrucous carcinoma of the head and neck Primož Strojan, Erika Šoba, Marjan Budihna, Journal of Surgical Oncology	2005	37
Preliminary studies of interstitial hyperthermia using hot water K Schreier, Marjan Budihna, Hotimir Lešničar, International Journal of Hyperthermia	1990	35

Page 1